Patanjali’s Herbal Psoriasis Treatment Earns Global Scientific Acclaim

Patanjali Ayurved has taken a notable leap toward global medical recognition, with its Ayurvedic treatment for psoriasis recently featured in the prestigious Journal of Inflammation Research. The study showcases the effectiveness of Patanjali’s herbal formulation, Psorogrit tablets and Divya-Taila (Divya oil), in managing psoriasis, a chronic autoimmune skin condition that causes inflammation, scaling, and redness

Conducted on preclinical models, including imiquimod and TPA-induced psoriasis in mice, the research demonstrated significant improvements in both skin condition and inflammation. The findings point to the formulation’s potential in addressing the root causes of psoriasis, rather than merely alleviating surface symptoms.

Acharya Balkrishna, a key figure in Patanjali’s research division, emphasized the study’s importance as a bridge between traditional Ayurvedic wisdom and modern scientific validation. This recognition not only bolsters Patanjali’s credibility in the global healthcare landscape but also opens new conversations around integrative and holistic approaches to treating chronic conditions.

As Ayurveda gains scientific validation, Patanjali’s breakthrough offers a beacon of hope for patients seeking safer, plant-based alternatives to conventional treatments, potentially redefining the future of psoriasis care.